These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
20 related articles for article (PubMed ID: 13934278)
1. A comparison of the biological activity of uracil mustard and Dopan. PETERING HG; BUSKIRK HH; MUSSER EA; EVANS JS Cancer Chemother Rep; 1963 Mar; 27():1-10. PubMed ID: 13942713 [No Abstract] [Full Text] [Related]
2. [A CASE OF ACUTE POISONING WITH DOPAN]. BOGORODSKAIA TA; MIKHAILOVA EN; OGIBINA LN; SHCHERBA MM Ter Arkh; 1965 Jan; 37():107-9. PubMed ID: 14342983 [No Abstract] [Full Text] [Related]
3. [REDUCING THE TOXICITY OF DOPAN BY MEANS OF AMINOETHYL-ISOTHIURONIUM (AET) IN EXPERIMENTS ON MONKEYS]. SPASSKAIA IG; PLATONOVA GN; SOLOPAEVA IM; SEMENOV LF; ZEITUNIAN KA; LARIONOV LF Vopr Onkol; 1963; 9():44-6. PubMed ID: 14148614 [No Abstract] [Full Text] [Related]
4. [EXPERIMENTAL STUDIES ON CARCINOMA AND ITS ARRESTED STATE. 9. PHARMACOLOGY OF URACIL MUSTARD, A CHEMOTHERAPEUTIC ANTINEOPLASTIC AGENT]. CHANG M Nihon Yakurigaku Zasshi; 1964 Sep; 60():413-34. PubMed ID: 14271233 [No Abstract] [Full Text] [Related]
5. Management of human leukemias and Hodgkin's disease with Dopan (uracil mustard). SAMPEY JR J S C Med Assoc; 1962 May; 58():175-6. PubMed ID: 14496660 [No Abstract] [Full Text] [Related]